Research Summary
Analyzed using Evidence Intelligence™

One-step OGTT may increase GDM diagnosis without improving outcomes

Last updated September 9, 2026

Key finding

The prevalence of GDM was numerically higher in the one-step 75 g OGTT approach compared with the two-step OGTT approach, but this difference did not reach statistical significance (12.9% vs 11.7%, p = .318).

This study compared two strategies for screening gestational diabetes: a two-step oral glucose tolerance test (OGTT) and a one-step OGTT. The one-step approach showed a numerically higher prevalence of gestational diabetes, but the difference was not statistically significant.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study compared two strategies for screening gestational diabetes: a two-step oral glucose tolerance test (OGTT) and a one-step OGTT. The one-step approach showed a numerically higher prevalence of gestational diabetes, but the difference was not statistically significant.

Clinical relevance

Understanding the effectiveness of different screening methods for gestational diabetes is crucial for improving maternal and fetal health. Although the one-step approach identified more cases, the lack of statistical significance suggests that both methods are similarly effective in clinical practice. This information can help healthcare providers make informed decisions about screening strategies.

Keep in mind

The study did not achieve statistical significance for the primary outcome. Sample size may limit the generalizability of the findings. Potential unmeasured confounders could affect the outcomes.

Published in

Journal Reference

Publication details and source links for this paper.

Batuhan T, Uğurcan Z, Harun K, et al. Comparison of Two-Step and One-Step Oral Glucose Tolerance Test Strategies for Gestational Diabetes Screening. Frontiers in Endocrinology. 2026;17:1793806. doi:10.3389/fendo.2026.1793806

Main Effects

Gestational diabetes prevalence was 12.9% in the one-step group vs 11.7% in the two-step group, p = NS.

Polyhydramnios incidence was similar: 6.1% in the one-step vs 6.5% in the two-step, p = 0.742.

Hypertensive disorders incidence was comparable: 5.9% in the one-step vs 6.1% in the two-step, p = 0.801.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to One-step method (75-gm 2-h OGTT), Two-step method (50-gm GCT followed by 100-gm OGTT) and Caesarean section rate, Gestational diabetes mellitus incidence, Hypertensive disorders incidence, and 4 more.

Primary intervention

One-step method (75-gm 2-h OGTT)

Primary outcomes

  • Caesarean section rate
  • Gestational diabetes mellitus incidence
  • Hypertensive disorders incidence

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

14
Evidence pairs
14
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 63

1

Related topics

14

Evidence pairs

49

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 14 evidence relationships
  • Includes primary outcome data
  • Linked to 1 direct semantic evidence topic

Topic contributions

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence topic

Diabetes Prevention

matched_outcome

Core evidence

Study findings

The primary outcomes reported in this study.

Caesarean section rate

One-step method (75-gm 2-h OGTT) → Caesarean section rate

One-step method (75-gm 2-h OGTT) → Caesarean section rate

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Gestational diabetes mellitus incidence

One-step method (75-gm 2-h OGTT) → Gestational diabetes mellitus incidence

One-step method (75-gm 2-h OGTT) → Gestational diabetes mellitus incidence

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Hypertensive disorders incidence

One-step method (75-gm 2-h OGTT) → Hypertensive disorders incidence

One-step method (75-gm 2-h OGTT) → Hypertensive disorders incidence

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Incidence of macrosomia

One-step method (75-gm 2-h OGTT) → Incidence of macrosomia

One-step method (75-gm 2-h OGTT) → Incidence of macrosomia

Evidence Intelligence™
EvidenceScore™
Moderate
Score 69 · Based on 2 studies
ImpactScore™
50
Neutral
ConsistencyScore™
100
consistent
Supporting studies: Based on 2 studies
Add to Evidence Tracker

Number of NICU admissions

One-step method (75-gm 2-h OGTT) → Number of NICU admissions

One-step method (75-gm 2-h OGTT) → Number of NICU admissions

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Polyhydramnios incidence

One-step method (75-gm 2-h OGTT) → Polyhydramnios incidence

One-step method (75-gm 2-h OGTT) → Polyhydramnios incidence

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Rate of preterm delivery (<37 weeks)

One-step method (75-gm 2-h OGTT) → Rate of preterm delivery (<37 weeks)

One-step method (75-gm 2-h OGTT) → Rate of preterm delivery (<37 weeks)

Evidence Intelligence™
EvidenceScore™
Moderate
Score 69 · Based on 2 studies
ImpactScore™
50
Neutral
ConsistencyScore™
100
consistent
Supporting studies: Based on 2 studies
Add to Evidence Tracker

Caesarean section rate

Two-step method (50-gm GCT followed by 100-gm OGTT) → Caesarean section rate

Two-step method (50-gm GCT followed by 100-gm OGTT) → Caesarean section rate

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Gestational diabetes mellitus incidence

Two-step method (50-gm GCT followed by 100-gm OGTT) → Gestational diabetes mellitus incidence

Two-step method (50-gm GCT followed by 100-gm OGTT) → Gestational diabetes mellitus incidence

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Hypertensive disorders incidence

Two-step method (50-gm GCT followed by 100-gm OGTT) → Hypertensive disorders incidence

Two-step method (50-gm GCT followed by 100-gm OGTT) → Hypertensive disorders incidence

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Incidence of macrosomia

Two-step method (50-gm GCT followed by 100-gm OGTT) → Incidence of macrosomia

Two-step method (50-gm GCT followed by 100-gm OGTT) → Incidence of macrosomia

Evidence Intelligence™
EvidenceScore™
Moderate
Score 69 · Based on 2 studies
ImpactScore™
50
Neutral
ConsistencyScore™
100
consistent
Supporting studies: Based on 2 studies
Add to Evidence Tracker

Number of NICU admissions

Two-step method (50-gm GCT followed by 100-gm OGTT) → Number of NICU admissions

Two-step method (50-gm GCT followed by 100-gm OGTT) → Number of NICU admissions

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Polyhydramnios incidence

Two-step method (50-gm GCT followed by 100-gm OGTT) → Polyhydramnios incidence

Two-step method (50-gm GCT followed by 100-gm OGTT) → Polyhydramnios incidence

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Rate of preterm delivery (<37 weeks)

Two-step method (50-gm GCT followed by 100-gm OGTT) → Rate of preterm delivery (<37 weeks)

Two-step method (50-gm GCT followed by 100-gm OGTT) → Rate of preterm delivery (<37 weeks)

Evidence Intelligence™
EvidenceScore™
Moderate
Score 69 · Based on 2 studies
ImpactScore™
50
Neutral
ConsistencyScore™
100
consistent
Supporting studies: Based on 2 studies
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • One-step OGTT showed a higher prevalence of gestational diabetes (12.9%) compared to two-step (11.7%).
  • Polyhydramnios rates were comparable between the two methods (6.1% vs 6.5%).
  • Hypertensive disorders were similar in both groups (5.9% vs 6.1%).
who this applies

Who this applies to

  • Pregnant women undergoing gestational diabetes screening.
  • Healthcare providers involved in maternal-fetal medicine.
keep in mind

Keep in Mind

  • The lack of statistical significance means results should be interpreted cautiously.
  • Findings may not apply to populations outside the study sample.
  • Further research may be needed to confirm these outcomes.
between the lines

Between the Lines

  • The study did not achieve statistical significance for the primary outcome.
  • Sample size may limit the generalizability of the findings.
  • Potential unmeasured confounders could affect the outcomes.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on One-step method (75-gm 2-h OGTT) and Incidence of macrosomia, One-step method (75-gm 2-h OGTT) and Rate of preterm delivery (<37 weeks).

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does One-step method (75-gm 2-h OGTT) reduce incidence of macrosomia?

Moderate Evidence

Current evidence does not show a clear reduction in incidence of macrosomia with One-step method (75-gm 2-h OGTT).

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Incidence of macrosomia

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | neutral | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does One-step method (75-gm 2-h OGTT) improve rate of preterm delivery (<37 weeks)?

Moderate Evidence

Current evidence does not show a clear benefit of One-step method (75-gm 2-h OGTT) for rate of preterm delivery (<37 weeks).

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Rate of preterm delivery (<37 weeks)

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | neutral | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Two-step method (50-gm GCT followed by 100-gm OGTT) reduce incidence of macrosomia?

Moderate Evidence

Current evidence does not show a clear reduction in incidence of macrosomia with Two-step method (50-gm GCT followed by 100-gm OGTT).

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Incidence of macrosomia

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | neutral | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Two-step method (50-gm GCT followed by 100-gm OGTT) improve rate of preterm delivery (<37 weeks)?

Moderate Evidence

Current evidence does not show a clear benefit of Two-step method (50-gm GCT followed by 100-gm OGTT) for rate of preterm delivery (<37 weeks).

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Rate of preterm delivery (<37 weeks)

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | neutral | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.